Anti-Malarial Prevents Cancer In Mice

Main Category: Lymphoma / Leukemia / Myeloma
Also Included In: Cancer / Oncology;  Biology / Biochemistry
Article Date: 21 Dec 2007 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:5 stars

5 (1 votes)


New data generated by a team of researchers from St Jude Children's Research Hospital, Memphis, and Scripps Research Institute, Jupiter, have indicated that the antimalarial drug chloroquine effectively prevents cancer in mouse models of two distinct human cancer syndromes, Burkitt lymphoma and ataxia telangiectasia. As discussed in the accompanying commentary by Chi Dang, from Johns Hopkins University School of Medicine, Baltimore, these results complement an old epidemiology study suggesting that malarial prophylaxis with chloroquine diminished the incidence of Burkitt lymphoma.

In the study, chloroquine was shown to inhibit the development of Myc-induced lymphomas (a mouse model of Burkitt lymphoma) and to inhibit the development of lymphomas in ATM-deficient mice (a mouse model of ataxia telangiectasia). By contrast, chloroquine did not inhibit the development of lymphomas in p53-deficient mice. Further analysis indicated that chloroquine induced cellular features of autophagy (self-eating) and mediated its effects by inducing lysosomal stress and provoking a p53-dependent cell death. The authors therefore suggested that modulating autophagy, either using chloroquine or other approaches, might provide a new avenue for the development of anticancer therapeutics.

###

Title: Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis

Author Contact:
Michael B. Kastan
St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

John L. Cleveland
The Scripps Research Institute, Jupiter, Florida, USA.

Accompanying Commentary Title:
Antimalarial therapy prevents Myc-induced lymphoma

Author Contact:
Chi V. Dang
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Source: Karen Honey
Journal of Clinical Investigation

Article adapted by Medical News Today from original press release.
Visit our lymphoma / leukemia / myeloma section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Karen Honey. "Anti-Malarial Prevents Cancer In Mice." Medical News Today. MediLexicon, Intl., 21 Dec. 2007. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/92496.php>

APA
Karen Honey. (2007, December 21). "Anti-Malarial Prevents Cancer In Mice." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/92496.php.

Please note: If no author information is provided, the source is cited instead.


Lymphoma / Leukemia / Myeloma

Most Popular Articles



Follow Our Lymphoma News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Lymphoma / Leukemia / Myeloma Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »